What was Alterola Biotech’s price range in the past 12 months?
Alterola Biotech lowest stock price was $0.20 and its highest was $0.20 in the past 12 months.
What is Alterola Biotech’s market cap?
Alterola Biotech’s market cap is $291.90K.
When is Alterola Biotech’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Alterola Biotech overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Alterola Biotech pay dividends?
Alterola Biotech does not currently pay dividends.
What is Alterola Biotech’s EPS estimate?
Alterola Biotech’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Alterola Biotech have?
Alterola Biotech has 1,459,502,100 shares outstanding.
Which hedge fund is a major shareholder of Alterola Biotech?
Currently, no hedge funds are holding shares in ABTI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Alterola Biotech
Alterola Biotech, Inc. is a pharmaceutical company dedicated to the research and development of cannabinoid and cannabinoid-like molecules. The firm primarily focuses on pioneering regulated pharmaceutical products for human and animal health, as well as regulated food items. Key activities also include the production of active pharmaceutical ingredients (APIs) and food-grade components. Furthermore, the company emphasizes drug formulation and advanced delivery systems to improve bioavailability, solubility, and overall stability. It operates out of Birkenhead, United Kingdom.